Mostrando 174,181 - 174,200 Resultados de 174,586 Para Buscar '"'39"', tiempo de consulta: 1.07s Limitar resultados
  1. 174181
  2. 174182
    “…The pooled estimates for SR for those receiving anti-CD20, bruton tyrosine kinase inhibitor (BTKi), or venetoclax were 13% (95% CI 1-32%, 6 studies, 367 patients, I (2) 88%), 42% (95% CI 17-71%, 3 studies, 319 patients, I (2) 75%), and 20% (95% CI 0-54%, 3 studies, 39 patients, I (2) 66%), respectively. The RR for those receiving treatment for their hematologic malignancy compared to those who were not receiving treatment was 0.51 (95% CI 0.37-0.71, 8 studies, 579 patients, I (2) 89%; Figure 3). . …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 174183
    “…In addition, there was very low‐certainty evidence, limited by risk of bias, inconsistency, and imprecision, for higher COHb in the heated tobacco use compared with abstinence group for intention‐to‐treat analyses (LMD 0.69, 95% CI 0.07 to 1.31; 3 studies, 212 participants), but lower COHb in per‐protocol analyses (LMD −0.32, 95% CI −1.04 to 0.39; 2 studies, 170 participants). Evidence concerning additional biomarkers is reported in the main body of the review. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 174184
  5. 174185
    por Abid, Leila, Hammami, Rania, Chamtouri, Ikram, Drissa, Meriam, Boudiche, Selim, Bahloul, MohamedAmine, BenSlima, Hedi, Sayahi, Khaled, Charfeddine, Selma, Allouche, Emna, Rais, Lamia, Kaab, Badr, IbnHadjamor, Hassen, BenFatma, Lilia, Garbaa, Riadh, Boukhris, Sabrine, Halima, Manel Ben, Amdouni, Nesrine, Ghorbel, Chaima, Soudani, Sabrine, Khaled, Imen, Triki, Syrine, Bouazizi, Feten, Jemai, Imen, Abdeljalil, Ouday, Ammar, Yemna, Farah, Amani, Neji, Adnen, Oumayma, Zeineb, Seghaier, Sana, Mokrani, Samir, Thawaba, Hamza, Sarray, Hela, Ouaghlani, Khalil, Thabet, Houssem, Mnif, Zeineb, Boujelban, Fatma, Sghaier, Mohamed, Khalifa, Roueida, Fourati, Sami, Kammoun, Yasmin, Abid, Syrine, Hamza, Chihab, Jeddou, Syrine Ben, Sabbah, Lassaad, Lakhdhar, Rim, Dammak, Najla, Sellami, Tarek, Herbegue, Basma, Koubaa, Alia, Triki, Faten, Ellouz, Tarek, Hmoudi, Aicha, BenAmeur, Ikhlas, Boukhchina, MohamedMongi, Abid, Neila, Wachtati, Wejdene, Nasrallah, Nizar, Houidi, Yousra, Meghaieth, Fathia, Ghodhbane, Elhem, Chayeb, Mounira, Chenik, Sarra, Kaabachi, Samira, Saadaoui, Nizar, BenAmeur, Ines, Affes, Moufida, Ouali, Sana, Chaker, Mouna, Naanaa, Hela, Dghim, Meriem, Jarrar, Mourad, Mnif, Jihene, Turki, Ahmed, Zairi, Ihsen, Langar, Jamel, Dardouri, Safa, Hchaichi, Imen, Chettaoui, Rafik, Essmat, Wajih, Chakroun, Amel, Mzoughi, Khadija, Mechmeche, Rachid, BenHalima, Afef, BenKhala, Sahar, Chtourou, Slim, Maalej, Abdelkader, Ayari, Mohsen, Hadrich, Moufid, Tlili, Rami, Azaiez, Fares, Bouhlel, Imen, Sahnoun, Samira, Jerbi, Habib, BenMrad, Imtinene, Riahi, Leila, Sahnoun, Mohamed, BenJemaa, Abdelhamid, BenSalem, Amel, Rekik, Bassem, BenDoudou, Maroua, Boujneh, Rachid, Joulak, Anissa, Mejdoub, Yosra, Gtif, Imen, Jribi, Gouider, Naffeti, Elyes, Gamra, Habib, BenYousef, Soraya, Sdiri, Wissem, BenHalima, Najeh, BenAmeur, Youssef, Kachboura, Salem, Kraiem, Sondes, Fehri, Wafa, Bazdeh, Leila, Mourali, MohamedSami, Milouchi, Sami, Drissa, Habiba, Maatouk, Faouzi, Zakhama, Lilia, Addad, Faouzi, Kammoun, Samir, Abdesselem, Salem
    Publicado 2022
    “…Most individuals were treated in the public sector (74%), 39.4% of patients were diabetic, 25.8% were obese, 44.6% were overweight and 14% were smokers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 174186
    “…L'obésité a été retrouvée comme facteur de risque de mauvais pronostic chez les patients asthmatiques lors de la saison 2017-2018 de grippe (ORa=2.22, IC95%[1.25-3.96]), le tabagisme (ORa=2.95, IC95% [1.67- 5.39]) et l'insuffisance cardiaque pour la saison 2018-2019 (ORa= 2.05, IC95%[1.03-4.15]). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 174187
    “…Le groupe ayant refusé la VTC était en moyenne significativement plus âgé (57,8 ± 16,4 ans vs 48 ± 14,4 ans (p < 0,0001)) et habitait à une distance moins importante de l’institution (p < 0,0001), mais il n’y avait pas différence selon le sexe avec 42,9 % d’hommes (175/408) en cas de refus de VTC vs 46,8 % d’hommes (108/231) (p = 0,39)). Le principal motif de refus était la volonté de rencontrer physiquement le praticien dans 65,7 % des cas (268/408). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 174188
    “…Six patients avaient été vaccinés par vaccin Bnt162b2 (46 %), avec un délai médian d’apparition de 16,5 jours [4–28], 5 par mRNA1273 (39 %) avec un délai de 3 jours [1–22] et 215 %) par ChAdOx1 après 4 et 5 jours. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 174189
    “…Comparés à l’ensemble des traitements, les vaccins anti-SARS-CoV-2 à base d’ARN étaient associés à une augmentation des déclarations de cas de maladie de Behçet (ROR : 1,6, IC95 % : 1,3, 2,0), d’artérite à cellules géantes (ROR : 4,2, IC95 % : 3,7–4,7), de polyangéite microscopique (ROR : 2,7, IC95 % : 1,8–3,9), de vasculopathie livedoïde (ROR : 3,8, IC95 % : 2,3–6,3) et de vascularite urticarienne (ROR : 2,8, IC95 % : 2,2–3,6). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 174190
    “…Owens (1966) reported that male = 8 2 (SD = 4.0) female = 8.5 (SD = 3.9) Parkes (1985) reported male (n = 146) x = 11.5 6 (SD = 3.3) female (n = 260) x = 12.6 (SD = 3.7). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 174191
    “…RESULTS: A total of 262 knees met inclusion criteria (Table 1). 117 underwent isolated MPFLr, 106 MPFLr and TTO, and 39 MPFLr and trochleoplasty. CDI was 1.13, 1.11, and 1.09 preoperatively in each group, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 174192
    “…Just after (vs just before) the emergence of the delta variant (n=44 835 in each cohort), increased risks of ischaemic stroke, epilepsy or seizures, cognitive deficit, insomnia, and anxiety disorders were observed, compounded by an increased death rate. With omicron (n=39 845 in each cohort), there was a lower death rate than just before emergence of the variant, but the risks of neurological and psychiatric outcomes remained similar. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 174193
    “…We found significant reductions in psychological violence victimization at 0–6 months (SMD = −0.34, 95% CI = −0.47 to −0.20) and at >6 months (SMD = −0.29, 95% CI = −0.39 to −0.18); however, at both time points, there were outlier studies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 174194
    “…Ninety-four revision procedures were performed at 6 to 24 months, most commonly for infection (39% [37 procedures]). The early revision group was younger than the unrevised group (mean age 64 years versus 68 years) and a between-group difference in American Society of Anesthesiologists (ASA) grade was noted. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 174195
    “…DESCRIPTION/METHOD: This 39-year-old South African origin gentleman was initially referred to the Rheumatology department in 2013 with throbbing pain in his hands and stiffness in heels associated with scalp and nail changes secondary to psoriasis. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 174196
    “…Patient’s confidence in managing their pain increased from 3.2/5 (range 2-5) to 3.9/5 (range 2-5). Paired T-tests on these scores showed a statistically significant difference in understanding chronic pain post PEW (P < 0.001), and in confidence in self-management post PEW (P < 0.001). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 174197
    por Møller, Pål, Seppälä, Toni, Dowty, James G., Haupt, Saskia, Dominguez-Valentin, Mev, Sunde, Lone, Bernstein, Inge, Engel, Christoph, Aretz, Stefan, Nielsen, Maartje, Capella, Gabriel, Evans, Dafydd Gareth, Burn, John, Holinski-Feder, Elke, Bertario, Lucio, Bonanni, Bernardo, Lindblom, Annika, Levi, Zohar, Macrae, Finlay, Winship, Ingrid, Plazzer, John-Paul, Sijmons, Rolf, Laghi, Luigi, Valle, Adriana Della, Heinimann, Karl, Half, Elizabeth, Lopez-Koestner, Francisco, Alvarez-Valenzuela, Karin, Scott, Rodney J., Katz, Lior, Laish, Ido, Vainer, Elez, Vaccaro, Carlos Alberto, Carraro, Dirce Maria, Gluck, Nathan, Abu-Freha, Naim, Stakelum, Aine, Kennelly, Rory, Winter, Des, Rossi, Benedito Mauro, Greenblatt, Marc, Bohorquez, Mabel, Sheth, Harsh, Tibiletti, Maria Grazia, Lino-Silva, Leonardo S., Horisberger, Karoline, Portenkirchner, Carmen, Nascimento, Ivana, Rossi, Norma Teresa, da Silva, Leandro Apolinário, Thomas, Huw, Zaránd, Attila, Mecklin, Jukka-Pekka, Pylvänäinen, Kirsi, Renkonen-Sinisalo, Laura, Lepisto, Anna, Peltomäki, Päivi, Therkildsen, Christina, Lindberg, Lars Joachim, Thorlacius-Ussing, Ole, von Knebel Doeberitz, Magnus, Loeffler, Markus, Rahner, Nils, Steinke-Lange, Verena, Schmiegel, Wolff, Vangala, Deepak, Perne, Claudia, Hüneburg, Robert, de Vargas, Aída Falcón, Latchford, Andrew, Gerdes, Anne-Marie, Backman, Ann-Sofie, Guillén-Ponce, Carmen, Snyder, Carrie, Lautrup, Charlotte K., Amor, David, Palmero, Edenir, Stoffel, Elena, Duijkers, Floor, Hall, Michael J., Hampel, Heather, Williams, Heinric, Okkels, Henrik, Lubiński, Jan, Reece, Jeanette, Ngeow, Joanne, Guillem, Jose G., Arnold, Julie, Wadt, Karin, Monahan, Kevin, Senter, Leigha, Rasmussen, Lene J., van Hest, Liselotte P., Ricciardiello, Luigi, Kohonen-Corish, Maija R. J., Ligtenberg, Marjolijn J. L., Southey, Melissa, Aronson, Melyssa, Zahary, Mohd N., Samadder, N. Jewel, Poplawski, Nicola, Hoogerbrugge, Nicoline, Morrison, Patrick J., James, Paul, Lee, Grant, Chen-Shtoyerman, Rakefet, Ankathil, Ravindran, Pai, Rish, Ward, Robyn, Parry, Susan, Dębniak, Tadeusz, John, Thomas, van Overeem Hansen, Thomas, Caldés, Trinidad, Yamaguchi, Tatsuro, Barca-Tierno, Verónica, Garre, Pilar, Cavestro, Giulia Martina, Weitz, Jürgen, Redler, Silke, Büttner, Reinhard, Heuveline, Vincent, Hopper, John L., Win, Aung Ko, Lindor, Noralane, Gallinger, Steven, Le Marchand, Loïc, Newcomb, Polly A., Figueiredo, Jane, Buchanan, Daniel D., Thibodeau, Stephen N., ten Broeke, Sanne W., Hovig, Eivind, Nakken, Sigve, Pineda, Marta, Dueñas, Nuria, Brunet, Joan, Green, Kate, Lalloo, Fiona, Newton, Katie, Crosbie, Emma J., Mints, Miriam, Tjandra, Douglas, Neffa, Florencia, Esperon, Patricia, Kariv, Revital, Rosner, Guy, Pavicic, Walter Hernán, Kalfayan, Pablo, Torrezan, Giovana Tardin, Bassaneze, Thiago, Martin, Claudia, Moslein, Gabriela, Ahadova, Aysel, Kloor, Matthias, Sampson, Julian R., Jenkins, Mark A.
    Publicado 2022
    “…Average cumulative incidences of CRC in path_MLH1 carriers at 70 years of age were 52% in males and 41% in females; for path_MSH2 50% and 39%; for path_MSH6 13% and 17% and for path_PMS2 11% and 8%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 174198
    “…Les associations les plus fortes étaient retrouvées pour la transplantation rénale (HRa 32 [28-37] et 34 [24-47]), la transplantation du poumon (HRa 14 [8,1-23] et 11 [1,5-88]), l'insuffisance rénale en dialyse (HRa 7,0 [5,9-8,2] et HRa 8,6 [6,3-12]), la trisomie 21 (HRa 3,9 [2,1- 7,3] et 45 [16-127]), le retard mental (HRa 3,6 [2,5-5,0] et 3,1 [1,0-10]) et le cancer actif du poumon (HRa 3,5 [2,7-4,4] et 6,5 [4,2-10]). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 174199
    “…The levels of serum indium and urine indium in indium-exposed workers were 39.3 μg/L and 11.0 ng/g creatinine. Increased lung damage markers, oxidative stress markers, and inflammation markers were found in indium-exposed workers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 174200
    por Gao, Chuanyu, Peters, Max, Kurver, Piet, Anbarasan, Thineskrishna, Jayaraajan, Keerthanaa, Manning, Todd, Cashman, Sophia, Nambiar, Arjun, Cumberbatch, Marcus, Lamb, Benjamin W., Pickard, Robert, Erotocritou, Paul, Smith, Daron, Kasivisvanathan, Veeru, Shah, Taimur T., Abboudi, H, Abdelmoteleb, H, Abu Yousif, M, Acher, P, Adams, R, Ager, M, Ahmed, I, Ajayi, L, Akintimehin, A, Akman, J, Al Hayek, S, Al‐Dhahir, W, Al‐Qassim, Z, Al‐Shakhshir, S, Alberto, M, Ali Abdaal, C, Arya, M, Assaf, N, Ayres, B, Badgery, H, Bateman, K, Bdesha, A, Bedi, N, Begum, R, Belal, M, Biyani, CS, Bolton, D, Bultitude, M, Burge, F, Bycroft, J, Cameron, F, Campbell, A, Cannon, A, Carrie, A, Chappell, B, Chin, AOL, Chow, K, Christidis, D, Clements, J, Coode‐Bate, J, Cronbach, P, Curry, D, Dasgupta, R, Demirel, S, Derbyshire, L, Din, W, Docherty, E, Edison, E, Eldred‐Evans, D, Ellis, G, Evans, S, Foley, R, Frymann, R, Gallagher, M, Gowardhan, B, Graham, J, Graham, S, Gray, S, Grice, P, Gupta, S, Hamad, S, Hann, G, Harris, A, Hatem, E, Hawary, A, Hayat, Z, Hayne, D, Hegazy, M, Henderson, J, Hendry, J, Ho, C, Hughes‐Hallet, A, Hussain, A, Hussain, Z, Ibrahim, H, Irving, S, Ivin, N, Jaffer, A, Jalil, R, Kashora, F, Kavia, R, Kerr, L, Khadouri, S, Khan, A, Khan, M, Khan, S, Koschel, S, Kozan, AA, Kum, F, Kynaston, H, Laird, A, Lavan, L, Lawrentschuk, N, Lee, JCM, Lee, S, Liew, M, Mackenzie, K, Malki, M, Manson‐Bahr, D, Mason, H, Matanhelia, M, Maw, J, Mbuvi, J, McCauley, N, McGrath, S, McKay, AC, Mcilhenny, C, Miakhil, I, Miller, M, Mirza, AB, Morrison‐Jones, V, Morrow, J, Mosey, R, Murtagh, K, Natarajan, M, Nehikhare, Y, Ness, D, Ng, A, Ngweso, S, Nkwam, N, Nyandoro, M, Nzenza, T, O'Brien, J, O'Rourke, J, Olaniyi, P, Olivier, J, Osman, B, Oyekan, A, Pang, K, Pankhania, R, Parwaiz, I, Parys, B, Patterson, J, Pearce, I, Phipps, S, Premakumar, Y, Probert, JL, Quinlan, D, Ratan, H, Reid, K, Rezacova, M, Rezvani, S, Rodger, F, Rogers, A, Ross, D, Rowbotham, C, Rujancich, P, Ruljancich, P, Sadien, I, Sakthivel, A, Saleemi, A, Samsudin, A, Sandhu, S, Seaward, L, Sharma, A, Sharma, S, Shergill, I, Shetty, A, Shingles, C, Simmons, L, Simpson, R, Simson, N, Singh, H, Smith, D, Sriprasad, S, Stammeijer, R, Steen, C, Stewart, H, Stonier, T, Suraparaj, L, Swallow, D, Symes, A, Symes, R, Tailor, K, Tait, C, Tam, JP, Tay, J, Tay, LJ, Tregunna, R, Tudor, E, Udovichich, C, Umez‐Eronini, N, Wang, L, Ward, A, Weeratunga, G, Withington, J, Wong, C, Wozniak, S, Yassaie, O, Young, M
    Publicado 2022
    “…At the end of the modelling process, gender: male (odds ratio [OR] 0.8, 95% confidence interval [CI] 0.64–1.01, P = 0.07), neutrophil count (OR 1.03, 95% CI 1.00–1.06, P = 0.08), hydronephrosis (OR 0.79, 95% CI 0.59–1.05, P = 0.1), hydroureter (OR 1.3, 95% CI 0.97–1.75, P = 0.08), stone size >5–7 mm (OR 0.2, 95% CI 0.16–0.25, P < 0.001), stone size >7 mm (OR 0.11, 95% CI 0.08–0.15, P < 0.001), middle ureter stone position (OR 0.59, 95% CI 0.43–0.81, P = 0.001), upper ureter stone position (OR 0.31, 95% CI 0.25–0.39, P < 0.001), medical expulsive therapy use (OR 1.36, 95% CI 1.1–1.67, P = 0.001), oral nonsteroidal anti‐inflammatory drug (NSAID) use (OR 1.3, 95% CI 0.99–1.71, P = 0.06), and rectal NSAID use (OR 1.17, 95% CI 0.9–1.53, P = 0.24) remained. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS